The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer

• Главные авторы: Zihong Wu (Автор), Jiamei Wang (Автор), Fengming You (Автор), Xueke Li (Автор), Chong Xiao (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2023-03-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) is the leading cause of cancer death in women. For patients with HER2-positive MBC, after the failure of multiple lines of treatment, there is no optimal line of therapy. A series of clinical trials confirmed tha...